Cigna looks great, and they just started paying a decent dividend. Blended P/E of 11 is pretty close to their adjusted operating earnings growth of 11.25%. Historic normal multiple is around 14.68. Technically the saucer here should provide appropriate demand on the downside, so I think odds are to the upside. The equity looks great for an investment.
AMD Adj Op Earnings Forecasted to be around 24%, Current P/E of 41 is pretty close to mean. 3.50LT Debt to Capital is ideal for higher interest rate environment. BBB- Credit rating. Good company, higher valuation that has a little room to revert. No harm in dabbling though
Earnings growth rate of 7.3%. Norm P/E 17.93. Current P/E is only 8.83, but forecasted estimates are increasing consistently for 2022, 2023 EPS 3.72% div yld
2% Div Yld Adjusted Op Earnings Growth 10% Blended P/E 15 Normal P/E 15.89 Consistent with 16% EPS Chg/Yr Value Estimate $66 Analyst Consensus $59.08
Adj earning growth rate of 13 with a P/E sub 13 and a div yield of 2.7%. This looks fantastically oversold here.
Microchip looks solid. Adjusted Op Er Growth of 17.9%. Blended P/E currently 17.40. Div of 1.27% that sits at about 18% payout ratio. 40 billion dollar market cap. Peg ratio 0.96
5% Div Yld with Current Blended P/E at 19.70 versus 5Y avg pf 21.41. Current risks is the BBB credit rating as well as the 53% LT debt/capital; however, the 9% or so earnings growth rate for a utility is pretty solid.
Has an adjusted earnings growth rate of 26.78% with a historic 12Y norm PE of 26.89 (5Y 20) and a current P/E of only 15. Intrinsic Value based on 15 P/E alone for 2022 estimates = $390. With an adjusted earnings growth rate of 13.09% across a 5Y span, this is a solid buy. Risks are the 72% Debt/Capital with interest rates being a risk as well as homefurnishing...
PII far below norm P/E ratio with 2% dividend yield. New highs would be the start of a nice bull run, imo. Also a very niche sector.
Low end channel tag, .618 RT from rising wedge. Seems like a long from here.
Gap up leading into a rising wedge. Lowering momentum. Put/Call Ratio increased with IV still relatively low. Room for a lot of downside in NYSE:HON